Bladder cancer, in addition to its reliance on ERK pathway activation, is also associated with a defect in the PI3K/Akt signaling pathway, which ensures that cancer cells continue to proliferate and escape apoptosis (132–134). The gene discussed is AKT1; the disease is urinary bladder carcinoma.